• CHK1 Inhibition in Breast Cancer: Impact of ER/PR Status

  2026-05-15

  This study demonstrates that the therapeutic response to CHK1 inhibition in breast cancer varies significantly according to estrogen and progesterone receptor (ER/PR) status. These findings clarify the mechanistic basis for response heterogeneity and inform the rational design of targeted therapy regimens.

• Trifluoperazine 2HCl: Applied Dopamine D2 Receptor Inhibitor

  2026-05-14

  Trifluoperazine 2HCl empowers researchers with ultra-potent dopamine D2 receptor inhibition and unique dual-utility in neuropharmacology and immune modulation. Recent evidence reveals its pivotal role in host-directed antibacterial workflows and advanced dopaminergic signaling assays.

• Epalrestat: Advancing Neuroprotection via KEAP1/Nrf2 Pathway

  2026-05-14

  This thought-leadership article examines the mechanistic and translational promise of Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, in neurodegenerative and diabetic complication research. Building on recent breakthroughs in KEAP1/Nrf2 pathway activation, we provide actionable guidance for translational researchers, detail protocol optimization, and articulate Epalrestat’s role in the evolving landscape of oxidative stress and polyol pathway inhibition.

• ATG4B Nuclear Translocation Impairs DNA Repair in AML Under

  2026-05-13

  This study reveals a molecular mechanism where energy deficiency in acute myeloid leukemia (AML) drives ATG4B into the nucleus, disrupting PRMT1-mediated DNA repair and promoting genomic instability. Targeting ATG4B restores DNA repair capacity and reduces AML progression, highlighting a novel metabolic vulnerability for therapeutic intervention.

• Puromycin dihydrochloride: Technical Use and Protocol Guidan

  2026-05-13

  Puromycin dihydrochloride is an aminonucleoside antibiotic used for rapid selection of stable cell lines expressing the pac gene and for precise studies of translation and ribosome function. It is best suited for workflows requiring highly selective inhibition of protein synthesis in both eukaryotic and prokaryotic systems. Applications outside these boundaries should be approached with caution due to specificity and cytotoxicity constraints.

• Isosteroidal Alkaloids from Fritillaria Suppress LPS-Driven

  2026-05-12

  This study rigorously demonstrates that four isosteroidal alkaloids isolated from Fritillaria species attenuate lipopolysaccharide-induced inflammation both in vitro and in vivo via MyD88- and TRIF-dependent signaling pathways. The findings clarify the molecular mechanisms of Fritillaria's traditional anti-inflammatory use and provide a foundation for further translational research in inflammatory disease models.

• Super-Enhancer LINC01977 Drives Early LUAD via TGF-β/Smad3 A

  2026-05-12

  Zhang et al. reveal that super-enhancer hijacking of the long noncoding RNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma through the canonical TGF-β/Smad3 signaling pathway. This study uncovers a feedback mechanism involving tumor-associated macrophages and highlights LINC01977 as a potential epigenetic therapeutic target.

• Technical Use of Angiotensin I/II (1-5) in RAS Research

  2026-05-11

  Angiotensin I/II (1-5) enables precise modeling of the renin-angiotensin system in cardiovascular and renal research, particularly for workflows examining blood pressure regulation and aldosterone release. It should not be used outside these defined mechanistic domains due to its specific biochemical profile and solubility requirements.

• Ridaforolimus: Applied mTOR Inhibition in Cancer Assays

  2026-05-11

  Ridaforolimus (Deforolimus, MK-8669) delivers potent, selective mTOR pathway inhibition for reproducible cancer and senescence studies. Learn how to unlock its full assay potential, troubleshoot workflow bottlenecks, and translate recent AI-driven discoveries into actionable protocols.

• IR-1061: Transforming Deep Tissue Imaging in Translational R

  2026-05-10

  This thought-leadership article explores how the near infrared fluorescent dye IR-1061 is redefining precision in vivo imaging, providing mechanistic insights and strategic guidance for translational researchers. Drawing on recent evidence from nanosystem engineering and workflow optimization, it critically assesses IR-1061’s role in overcoming biological barriers and driving responsible innovation in biomedical imaging.

• Adefovir (GS-0393): Protocol-Driven Advances in HBV Research

  2026-05-09

  Adefovir (GS-0393) transforms hepatitis B virus research with precise DNA polymerase inhibition and robust selectivity, enabling both mechanistic virology studies and transporter assays. This guide delivers evidence-backed workflows, troubleshooting, and insights into maximizing assay reliability with APExBIO's high-purity Adefovir.

• Lipo3K Transfection Reagent: Optimizing Difficult Cell Trans

  2026-05-08

  Lipo3K Transfection Reagent delivers high-efficiency nucleic acid delivery in even the most challenging cell types, with minimal cytotoxicity and robust performance for both gene expression and RNA interference studies. Its dual-component system and serum compatibility make it a superior lipid transfection reagent for advanced research workflows.

• EPZ5676: Precision DOT1L Inhibition for MLL Leukemia Researc

  2026-05-08

  Explore the unique mechanism, selectivity, and assay integration of EPZ5676, a potent DOT1L inhibitor, for MLL-rearranged leukemia research. This article offers advanced protocol guidance and insights not found in existing content.

• GSK J4 HCl: Precision Targeting of JMJD3 in Immune Regulatio

  2026-05-07

  Discover how GSK J4 HCl, a potent JMJD3 inhibitor, enables advanced investigation of histone demethylation and immune modulation. Explore unique insights into CXCL10 regulation and translational assay design for inflammatory and epigenetic research.

• Trypsin as a Serine Protease: Optimizing Cell Assays & Beyon

  2026-05-07

  Unlock the full power of Trypsin as a precision serine protease for cell proliferation, differentiation, and advanced proteolytic workflows. Discover evidence-based parameters and troubleshooting strategies that set APExBIO’s Trypsin (BA5744) apart in wound healing and genomic stability research.

530 records 8/36 page Previous Next First page 上5页 678910 下5页 Last page